Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma

Clinical trial NCT04525859 · COMPLETED

Trial details

NCT number: NCT04525859
Sponsor: Oncovir, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Pleural Mesothelioma

Start date: 2020-08-19
Primary completion: 2025-06-18
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.